Safety Alerts for Human Medical Products > Heparin Sodium (B. Braun): Recall
November 1, 2010 – Last week, B. Braun Medical Inc. announced a nationwide recall of certain lots of Heparin Sodium USP Active Pharmaceutical Ingredient (API) sold to the company because testing indicated a trace amount of over sulfated chondroitin sulfate (OSCS) contaminant.
The recalled lots were manufactured in 2008 and have expiration dates of October 31, 2010 and November 30, 2010. Customers who have product from the recalled product lots in their possession should discontinue use immediately.
What is Heparin?
Heparin is an anticoagulant produced naturally in the lungs and liver. It may be administered as a medication to address blood clotting disorders such as thrombosis, typically in a hospital setting. This drug can be extremely dangerous if it is used improperly or without supervision, and a number of precautions need to be observed when administering heparin to ensure that the drug does not cause complications in the patient.